Balyasny Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-262,702	Closed	-$15.5M	–	2881
2022 Q3	$15.5M	Buy	262,702 +21,116	+9%	+$1.25M	0.05%	421
2022 Q2	$6.82M	Buy	+241,586	New	+$6.82M	0.02%	660